Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:43:26.814Z.
Consensus retrieved: 2026-10-06T14:38:18.972Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:43:26.814Z.
Quote observation: 2026-10-06T17:39:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 88249fb6bbade3b4ad802b4bad00c79a42ee89cc3a650020707e3f27628c9d48
FORWARD PE RATIO
N/A
Nyxoah S.A.
Market Cap
$143.10M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Nyxoah S.A. (NYXH) | $143.10M | N/A |
| Protara Therapeutics, Inc. (TARA)vs › | $142.48M | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.28M | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $141.58M | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $145.54M | N/A |
| Immuneering Corporation (IMRX)vs › | $140.31M | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 6.96 |
| Anavex Life Sciences Corp. (AVXL)vs › | $147.13M | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.54M | N/A |
| Alpha Cognition Inc (ACOG)vs › | $137.92M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in EUR, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
